Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes

Pharmacology

Volumn 60, Issue 3, 2000, Pages 143-154

  DeLeve, Laurie D ^a,b   Wang, Xiangdong ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Busulfan; Cell, cultured; Glutathione; Glutathione transferase; Hepatic veno occlusive disease; Hepatitis, toxic; Oxidative stress

Indexed keywords

ANTIOXIDANT; BUSULFAN; CARMUSTINE; CIBACRON BLUE F3GA; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG CONJUGATION; DRUG METABOLISM; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0034025774     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028359     Document Type: Article

References (30)

1. Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR: Allogeneic hone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamidc (BuCy2). Semin Oncol 1993;20:33-38.
2. Atkinson K, Biggs J, Noble G, Ashby M, Concannon A, Dodds A: Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cytitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant 1987;2: 385-394.
3. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation - A cohort study of 355 patients. Ann Intern Med 1993;118:255-267.
4. DeLeve LD: Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation. Hepatology 1996;24:830-837.
5. Méresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugières L, Lemerle J: Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: A study in 136 children. Bone Marrow Transplant 1992;10:135-141.
6. Roberts JJ, Warwick GP: Metabolism of myleran (1,4-dimethanesulphonyloxybutane). Nature 1959;183:1509-1510.
7. Hassan M, Ehrsson H: Urinary metabolites of busulfan in the rat. Drug Metab Dispos 1987; 15:399-402.
8. Marchand DH, Remmel RP, Abdel-Monem MM: Biliary excretion of a glutathione conjugate of busulfan and 1,4-diiodobutane in the rat. Drug Metab Dispos 1988;16:85-92.
9. Czerwinski M, Gibbs JP, Slattery JT: Busulfan conjugation by glutathione S-transferases α, μ and π. Drug Metab Dispos 1996;24:1015-1019.
10. Addison IE, Berenbaum MC: The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer 1971;25:172-181.
11. DeLeve LD: Dacarhazine toxicity in murine liver cells: A novel model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 1994;268:1261-1270.
12. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N: Toxicity of azathioprine and monocrotaline in murine sinuosidal endothelial cells and hepatocytes: The role of glutathionc and relevance to hepatic venooclusive disease. Hepatology 1996;23:589-599.
13. Reed DJ, Babson TR, Beetty DW, Brodie AE, Ellis WW, Potter DW: High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and selected thiols and disulfides. Anal Biochem 1980;106:55-62.
14. Fariss MW, Reed DJ: High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives. Methods Enzymol 1987; 143:101-109.
15. Martin J, White INH: Fluorimetric determination of oxidised and reduced glutathione in cells and tissues by high-performance liquid chromatography following derivatization with dansyl chloride. J Chromatogr A 1991;568: 219-225.
16. Jones DP, Maellaro E, Jiang S, Slater AFG, Orrenius S: Effects of N-acetyl-L-cysteine on T-cell apoptosis are not mediated by increased cellular glutathione. Immunol Lett 1995;45: 205-209.
17. Wong SHY, Knight JA, Hopler SM, Zaharia O, Leach CN Jr, Sunderman FW Jr: Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehydethiobarbituric acid adduct. Clin Chem 1987; 33:214-220.
18. Wallin B, Rosengren B, Shertzer HG, Camejo G: Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: Its use for evaluation of antioxidants. Anal Bioehem 1993; 208:11-15.
19. Snedecor GW, Cochran WG: Statistical Methods. Ames, The Iowa State University Press, 1980.
20. Kaplowitz N: Enzymatic thiolysis of azathioprine in vitro. Biochem Pharmacol 1976;25: 2421-2426.
21. Kaplowitz N, Kuhlenkamp JF: Inhibition of hepatic metabolism of azathioprine in vivo. Gastrocnterology 1978;74:90-92.
22. Ohta Y, Kohda K, Kimoto H, Okano T, Kawazoe Y: Cytotoxicity of fluorine-containing alkyl alkanesulfonates to cultured leukemia L1210 cells. Chem Pharm Bull 1988;36:2410-2416.
23. Millar BC, Tilby MJ, Ormerod MG, Payne AW, Jinks S, Loverock PS: Comparative studies of total cross-linking, cell survival and cell cycle perturbations in Chinese hamster cells treated with alkylating agents in vitro. Biochem Pharmacol 1986;35:1163-1169.
24. Puri EC, Baumeister M, Fautz R, Hechenberger CM, Hertner T, Meli C, Miltenburger HG, Schmid B, Schwegler R, Seeberg AM: Inter-laboratory ring trial of in vitro DNA repair tests using rat hepatocytes: Further testing and conclusive remarks. Mutagenesis 1991;6:471-478.
25. Hemminki K, Kallama S, Falck K: Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs. Ada Pharmacol Toxicol 1983;53:421-428.
26. Ponti M, Souhami RL, Fox BW, Hartley JA: DNA interstrand crosslinking and sequence selectivity of dimethanesulphonates. Br J Cancer 1991;63:743-747.
27. Hassan M, Ljungman P, Bolme P, Ringdén O, Syrücková Z. Békassy A, Stary J, Wallin I, Källberg N: Busulfan bioavailability. Blood 1994; 84:2144-2150.
28. Gibbs JP, Yang JS, Slattery JT: Comparison of human liver and small intestinal glutathione S-transferase-catalyzed busulfan conjugation in vitro. Drug Metab Dispos 1998;26:52-55.
29. 11C]-busulfan in cynomolgus monkey and in the brain of a human patient. Cancer Chemother Pharmacol 1992;30:81-85.
30. Gibbs JP, Czerwinski M, Slattery JT: Busulfanglutathione conjugation catalyzed by human liver cytosolic glutathionc S-transferases. Cancer Res 1996;56:3678-3681.